ISN-DOPPS Webinar: Cardiovascular Disease in Patients with Moderate to Advanced CKD – Traditional Risk Factors and Important New Opportunities

Cardiovascular disease is a major cause of morbidity and mortality in patients with CKD. There are evidence-based guideline availableto guide practice in many aspects of CVD in CKD, but practice in real world varies significantly. In this webinar we provide an overview of the current practice in the management of hypertension, dyslipidemia and anemia, and discuss how understanding clinical practice variation can lead to the definition of strategies to improve outcomes.

Learning Objectives:

1. Learn about how treatment of dyslipidemia in CKD varies across countries

2. Understand the current approach to managing hypertension in patients with CKD and provide an overview of practice variation

3. Discuss unmet need in the management of iron deficiency

Roberto Pecoits-Filho


Dr. Pecoits-Filho is a Senior Research Scientist at Arbor Research Collaborative for Health in Michigan, USA and a Professor of Medicine, Pontifical Catholic University of Paraná in Curitiba, Brazil. He is the current (2021-23) Chair of the Education Committee of the International Society of Nephrology. As a clinician, he has broad activities in Internal Medicine and Nephrology based at the University affiliated hospitals, where he was the Chief of the Department of Internal Medicine between 2010 and 2016, the Director of the Residency program in Nephrology from 2013 to 2016. Dr. Pecoits-Filho is the Principal Investigator for the study CKDOPPS, a multinational study on practice patterns and outcomes in chronic kidney disease and act as a Scientific Leader for clinical trials in the Americas with George Clinical. Dr. Pecoits-Filho received his MD and trained in Internal Medicine and Nephrology in Curitiba, Brazil before completing a nephrology research fellowship at the University of Missouri, Columbia and a PhD from the University of Sao Paulo. He was a visiting scholar for extended periods at the Karolinska Institute (Sweden) and the George Institute (Australia), and has participated as a principal investigator, regional leader and in steering committees in multinational clinical trials. Dr. Pecoits-Filho served as a member of the Executive Committee of the International Society of Nephrology (ISN) (2017-2019), the SONG Initiative (2017-present) and KDIGO (2016-2018).

Murilo Guedes


Michelle Wong


David Charytan


Christian Combe


Viviane Calice-Silva



Open to view video.
Open to view video. ISN-DOPPS Webinar: Cardiovascular disease in patients with moderate to advanced CKD – Traditional Risk Factors and Important New Opportunities